Aurobindo Pharma Ltd has received marketing authorization approval from Medicines Control Council (MCC) of South Africa. The council has approved amoxycillin capsules in 250mg and 500mg strengths.

South African market is highly regulated and plays pivotal role in its Geographical sphere. The company, have got this approval is now well positioned to participate in Antibiotic, CNS, CVS, and ARV segments of South African markets.

Amoxicllin is a Beta-lactam antibiotic used often in treating respiratory infections. GSK is the inventor of this antibiotic and is marketed under the brand name Amoxil in most parts of the world. The company is successfully marketing amoxicillin in US.

Amoxicillin commands a market of 56mio USD in South Africa.